Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationInvest. Ophthalmol. Vis. Sci. 1996, 37(6):1199-203
AbstractPURPOSE: To test an aqueous eye drop solution containing a high concentration of dexamethasone in a cyclodextrin-based drug delivery system. This system increases both drug solubility in aqueous eye drops and drug permeability into the eye, through drug cyclodextrin-polymer co-complexes. METHODS: 2-hydroxypropyl-beta-cyclodextrin is a water-soluble oligosaccharide that can be used to dissolve lipophilic drugs, such as dexamethasone, in aqueous solutions. Co-complexation with a polymer further increases the solubility and increases drug permeability through biologic membranes. Eye drops containing dexamethasone (0.32% and 0.67%), 2-hydroxypropyl-beta-cyclodextrin, and polymer were given to patients before cataract surgery, and the resultant dexamethasone concentration was measured from aqueous humor samples. RESULTS: The dexamethasone-cyclodextrin drops give a significantly higher concentration of dexamethasone in aqueous humor than dexamethasone alcohol 0.1% (Maxidex). Heating of the dexamethasone-cyclodextrin-polymer co-complexes appears to enhance the permeability of the drug into the eye. CONCLUSIONS: The cyclodextrin-based drug delivery system enhances both the solubility of dexamethasone in aqueous eye drops and the permeability of the drug into the human eye. Dexamethasone concentration levels in the human aqueous humor exceed those reported with currently available steroid eye drops.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
- Authors: Wang S, Li D, Ito Y, Nabekura T, Wang S, Zhang J, Wu C
- Issue date: 2004 Jul
- Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
- Authors: Moya-Ortega MD, Alves TF, Alvarez-Lorenzo C, Concheiro A, Stefánsson E, Thorsteinsdóttir M, Loftsson T
- Issue date: 2013 Jan 30
- Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
- Authors: Loftsson T, Hreinsdóttir D, Stefánsson E
- Issue date: 2007 May
- Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
- Authors: Zhang L, Zhang J, Wang L, Xia H
- Issue date: 2009 Apr
- Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
- Authors: Kesavan K, Kant S, Singh PN, Pandit JK
- Issue date: 2011 Oct